Express Scripts (NASDAQ:ESRX) Coverage Initiated at Evercore ISI

Evercore ISI started coverage on shares of Express Scripts (NASDAQ:ESRX) in a research note published on Thursday, January 4th, Marketbeat reports. The firm issued an in-line rating and a $78.00 target price on the stock.

A number of other brokerages also recently weighed in on ESRX. BidaskClub raised shares of Express Scripts from a buy rating to a strong-buy rating in a research note on Friday, December 22nd. SunTrust Banks set a $86.00 price target on shares of Express Scripts and gave the company a buy rating in a research report on Thursday, December 21st. Needham & Company LLC reiterated a hold rating on shares of Express Scripts in a research report on Thursday, December 21st. Royal Bank of Canada set a $68.00 target price on shares of Express Scripts and gave the stock a hold rating in a report on Friday, December 15th. Finally, Jefferies Group set a $80.00 target price on shares of Express Scripts and gave the stock a buy rating in a report on Friday, December 15th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company’s stock. Express Scripts currently has an average rating of Hold and an average target price of $77.09.

Express Scripts (ESRX) opened at $80.87 on Thursday. The firm has a market cap of $45,360.00, a PE ratio of 13.43, a P/E/G ratio of 0.89 and a beta of 0.87. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts has a 1 year low of $55.80 and a 1 year high of $81.75.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.90. The firm had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.74 earnings per share. equities analysts forecast that Express Scripts will post 7.04 EPS for the current year.

Express Scripts declared that its board has initiated a stock repurchase program on Monday, December 18th that authorizes the company to repurchase 45,000,000 shares. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company’s board of directors believes its shares are undervalued.

In other news, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction dated Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the transaction, the vice president now owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Christine Houston sold 10,104 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the transaction, the vice president now directly owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,644 shares of company stock valued at $1,289,609. 0.68% of the stock is owned by insiders.

Large investors have recently modified their holdings of the business. Burt Wealth Advisors grew its stake in shares of Express Scripts by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after purchasing an additional 174 shares during the period. Bank of Nova Scotia Trust Co. bought a new position in shares of Express Scripts during the 3rd quarter valued at approximately $120,000. First Personal Financial Services grew its stake in shares of Express Scripts by 199.1% during the 2nd quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after acquiring an additional 1,400 shares during the period. Monroe Bank & Trust MI grew its stake in shares of Express Scripts by 74.8% during the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after acquiring an additional 970 shares during the period. Finally, Capstone Investment Advisors Netherlands B.V. grew its stake in shares of Express Scripts by 49.3% during the 2nd quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock valued at $179,000 after acquiring an additional 924 shares during the period. 88.28% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Express Scripts (NASDAQ:ESRX) Coverage Initiated at Evercore ISI” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/express-scripts-esrx-coverage-initiated-at-evercore-isi.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply